| Washington state sues OxyContin maker Purdue Pharma | | | (Reuters) - Washington state on Thursday sued OxyContin maker Purdue Pharma LP, becoming the latest state or local government to file a lawsuit seeking to hold pharmaceutical companies accountable for a national opioid addiction epidemic. |
| |
| A single genetic glitch may explain how Zika became so dangerous | | | CHICAGO (Reuters) - A single genetic change that occurred in 2013 may explain how Zika acquired the ability to attack fetal nerve cells, causing a severe birth defect in babies whose mothers were infected while pregnant, Chinese and U.S. researchers reported on Thursday. |
| |
| Makers of fast-acting opioids will have to pay for training: FDA | | | NEW YORK (Reuters) - Makers of fast-acting opioids will have to fund voluntary training for healthcare professionals who prescribe the drugs, including education on safe prescribing practices and non-opioid alternatives, the U.S. Food and Drug Administration (FDA) said on Thursday. |
| |
| PTC Therapeutics Duchenne drug may work, data inconclusive: FDA panel | | | (Reuters) - PTC Therapeutics Inc's experimental drug to treat Duchenne muscular dystrophy, a devastating degenerative disease that mostly affects young boys, may work but the company will need to do more work to prove it, an advisory panel to the U.S. Food and Drug Administration concluded on Thursday. |
| |
| Trial data suggest new typhoid shot could halve infection rate | | | LONDON (Reuters) - A new typhoid vaccine developed by privately-held Bharat Biotech proved safe and highly immunogenic in a study and could be used to prevent millions of infections if it succeeds in final-stage clinical trials, researchers said on Friday. |
| |
| | |
